Photo from Cancer at Cedars-Sinai/X
Apr 28, 2024, 12:40
Cancer at Cedars-Sinai is now recruiting patients with advanced NSCLC in a clinical trial
Cancer at Cedars-Sinai posted on X/Twitter:
“If you have advanced non-small cell lung cancer, you may be eligible for a clinical trial that compares usual treatment options to a study treatment combining Keytruda (pembrolizumab) and Cyramza (ramucirumab).”
Source: Cancer at Cedars-Sinai/X